Creo Medical Group PLC buy krebskrebs
Start price
29.11.21
/
50%
€1.55
Target price
29.11.22
€2.00
Performance (%)
-72.13%
End price
30.11.22
€0.43
Summary
This prediction ended on 30.11.22 with a price of €0.43. Massive losses of -72.13% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Creo Medical Group PLC | 3.627% | 3.627% | 45.985% |
iShares Core DAX® | -0.268% | 5.471% | 14.271% |
iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% |
iShares Nikkei 225® | 0.284% | 1.729% | 9.943% |
iShares S&P 500 | 1.178% | 5.269% | 27.989% |
Comments by krebskrebs for this prediction
In the thread Creo Medical Group PLC diskutieren
Buy mit Kursziel 2,0
In the thread Trading Creo Medical Group PLC
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten